(1->4)-beta-D-glucan multiple interactions ISO RGD:1321288 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HNRNPA2B1 mRNA CTD PMID:36331819 1,2-dichloroethane increases expression ISO RGD:1321288 6480464 ethylene dichloride results in increased expression of HNRNPA2B1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1321288 6480464 1, 2-Dimethylhydrazine results in decreased expression of HNRNPA2B1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1321288 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HNRNPA2B1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of HNRNPA2B1 mRNA CTD PMID:12832660 17beta-estradiol increases expression ISO RGD:1321287 6480464 Estradiol results in increased expression of HNRNPA2B1 mRNA CTD PMID:16514628 17beta-estradiol affects expression ISO RGD:1321288 6480464 Estradiol affects the expression of HNRNPA2B1 mRNA CTD PMID:15598610 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1321288 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1321288 6480464 Tetrachlorodibenzodioxin affects the expression of HNRNPA2B1 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HNRNPA2B1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HNRNPA2B1 mRNA CTD PMID:34747641 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19954255 2,6-di-tert-butyl-4-methylphenol multiple interactions ISO RGD:1321288 6480464 [Methylcholanthrene co-treated with Butylated Hydroxytoluene] affects the expression of HNRNPA2B1 protein CTD PMID:17477362 2-amino-14,16-dimethyloctadecan-3-ol increases expression ISO RGD:1321287 6480464 2-amino-14, 16-dimethyloctadecan-3-ol results in increased expression of HNRNPA2B1 protein CTD PMID:32044396 3',5'-cyclic UMP affects binding ISO RGD:1321287 6480464 HNRNPA2B1 protein binds to cyclic 3', 5'-uridine monophosphate CTD PMID:30528433 3-methylcholanthrene multiple interactions ISO RGD:1321288 6480464 [Methylcholanthrene co-treated with Butylated Hydroxytoluene] affects the expression of HNRNPA2B1 protein CTD PMID:17477362 4,4'-diaminodiphenylmethane increases expression ISO RGD:1321288 6480464 4, 4'-diaminodiphenylmethane results in increased expression of HNRNPA2B1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HNRNPA2B1 mRNA CTD PMID:36041667 4-phenylbutyric acid decreases expression ISO RGD:1321287 6480464 4-phenylbutyric acid results in decreased expression of HNRNPA2B1 mRNA CTD PMID:14583596 5-aza-2'-deoxycytidine decreases expression ISO RGD:1321287 6480464 Decitabine results in decreased expression of HNRNPA2B1 protein CTD PMID:19294695 5-aza-2'-deoxycytidine affects expression ISO RGD:1321287 6480464 Decitabine affects the expression of HNRNPA2B1 mRNA CTD PMID:23300844 5-fluorouracil multiple interactions ISO RGD:1321287 6480464 TP53 protein affects the reaction [Fluorouracil results in decreased expression of HNRNPA2B1 mRNA] CTD PMID:15016801 7,12-dimethyltetraphene affects expression ISO RGD:1321288 6480464 9 more ... CTD PMID:21785161 9-cis-retinoic acid decreases expression ISO RGD:1321287 6480464 Alitretinoin results in decreased expression of HNRNPA2B1 protein CTD PMID:28886987 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of HNRNPA2B1 mRNA CTD PMID:28959563 afimoxifene decreases expression ISO RGD:1321287 6480464 afimoxifene results in decreased expression of HNRNPA2B1 mRNA CTD PMID:16514628 aflatoxin B1 decreases methylation ISO RGD:1321287 6480464 Aflatoxin B1 results in decreased methylation of HNRNPA2B1 gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO RGD:1321287 6480464 aflatoxin B2 results in increased methylation of HNRNPA2B1 intron CTD PMID:30157460 aldosterone increases expression EXP 6480464 Aldosterone results in increased expression of HNRNPA2B1 mRNA, Aldosterone results in increased expression of HNRNPA2B1 protein CTD PMID:23139218 all-trans-retinoic acid increases expression ISO RGD:1321287 6480464 Tretinoin results in increased expression of HNRNPA2B1 protein CTD PMID:28886987 aristolochic acid A decreases expression ISO RGD:1321287 6480464 aristolochic acid I results in decreased expression of HNRNPA2B1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1321288 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HNRNPA2B1 mRNA CTD PMID:23650126 arsane increases expression ISO RGD:1321287 6480464 Arsenic results in increased expression of HNRNPA2B1 CTD PMID:35363433 arsenic atom increases expression ISO RGD:1321287 6480464 Arsenic results in increased expression of HNRNPA2B1 CTD PMID:35363433 arsenite(3-) increases methylation ISO RGD:1321287 6480464 arsenite results in increased methylation of HNRNPA2B1 promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:1321287 6480464 Arsenic Trioxide results in decreased expression of HNRNPA2B1 protein CTD PMID:25419056 benzo[a]pyrene increases expression ISO RGD:1321288 6480464 Benzo(a)pyrene results in increased expression of HNRNPA2B1 mRNA CTD PMID:20127859 benzo[a]pyrene affects methylation ISO RGD:1321287 6480464 Benzo(a)pyrene affects the methylation of HNRNPA2B1 intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1321287 6480464 Benzo(a)pyrene results in increased expression of HNRNPA2B1 protein CTD PMID:18495319 benzo[a]pyrene affects expression ISO RGD:1321288 6480464 Benzo(a)pyrene affects the expression of HNRNPA2B1 mRNA CTD PMID:22342234 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1321287 6480464 7 more ... CTD PMID:20018196 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HNRNPA2B1 mRNA, [Fructose co-treated with bisphenol A] results in increased expression of HNRNPA2B1 protein CTD PMID:26930160 , PMID:36041667 bisphenol A decreases expression ISO RGD:1321288 6480464 bisphenol A results in decreased expression of HNRNPA2B1 mRNA CTD PMID:32156529 , PMID:33221593 bisphenol A affects expression ISO RGD:1321287 6480464 bisphenol A affects the expression of HNRNPA2B1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1321287 6480464 bisphenol A results in decreased expression of HNRNPA2B1 mRNA, bisphenol A results in decreased expression of HNRNPA2B1 protein CTD PMID:29275510 , PMID:34186270 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of HNRNPA2B1 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO RGD:1321287 6480464 bisphenol B results in increased expression of HNRNPA2B1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1321287 6480464 bisphenol F results in increased expression of HNRNPA2B1 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HNRNPA2B1 mRNA CTD PMID:36041667 bleomycin A2 increases expression EXP 6480464 Bleomycin results in increased expression of HNRNPA2B1 protein CTD PMID:25933445 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of HNRNPA2B1 mRNA CTD PMID:24136188 butanal decreases expression ISO RGD:1321287 6480464 butyraldehyde results in decreased expression of HNRNPA2B1 mRNA CTD PMID:26079696 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of HNRNPA2B1 mRNA CTD PMID:19010381 caffeine decreases phosphorylation ISO RGD:1321287 6480464 Caffeine results in decreased phosphorylation of HNRNPA2B1 protein CTD PMID:35688186 canrenoic acid multiple interactions EXP 6480464 Canrenoic Acid inhibits the reaction [Sodium, Dietary deficiency results in increased expression of HNRNPA2B1 mRNA] CTD PMID:23139218 carbon nanotube affects expression ISO RGD:1321287 6480464 Nanotubes, Carbon affects the expression of HNRNPA2B1 protein CTD PMID:22001959 carbon nanotube increases expression ISO RGD:1321288 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1321287 6480464 Nanotubes more ... CTD PMID:22157353 , PMID:24389112 chloropicrin affects expression ISO RGD:1321287 6480464 chloropicrin affects the expression of HNRNPA2B1 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1321288 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HNRNPA2B1 gene CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of HNRNPA2B1 protein CTD PMID:22023808 cisplatin decreases expression ISO RGD:1321288 6480464 Cisplatin results in decreased expression of HNRNPA2B1 protein CTD PMID:29733421 cisplatin affects expression ISO RGD:1321287 6480464 Cisplatin affects the expression of HNRNPA2B1 mRNA CTD PMID:23300844 cisplatin decreases expression ISO RGD:1321287 6480464 Cisplatin results in decreased expression of HNRNPA2B1 mRNA CTD PMID:27594783 clofibrate increases expression ISO RGD:1321288 6480464 Clofibrate results in increased expression of HNRNPA2B1 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1321287 6480464 cobaltous chloride results in decreased expression of HNRNPA2B1 mRNA CTD PMID:19320972 copper atom affects splicing ISO RGD:1321288 6480464 Copper affects the splicing of HNRNPA2B1 mRNA CTD PMID:21146535 copper atom affects binding ISO RGD:1321287 6480464 HNRNPA2B1 protein binds to Copper CTD PMID:15359738 copper atom multiple interactions ISO RGD:1321287 6480464 [Disulfiram binds to Copper] which results in increased expression of HNRNPA2B1 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of HNRNPA2B1 mRNA CTD PMID:20971185 , PMID:24690739 copper atom affects localization ISO RGD:1321288 6480464 Copper affects the localization of HNRNPA2B1 protein CTD PMID:21146535 copper atom increases expression ISO RGD:1321288 6480464 Copper results in increased expression of HNRNPA2B1 mRNA more ... CTD PMID:16629173 , PMID:21146535 copper(0) affects splicing ISO RGD:1321288 6480464 Copper affects the splicing of HNRNPA2B1 mRNA CTD PMID:21146535 copper(0) affects binding ISO RGD:1321287 6480464 HNRNPA2B1 protein binds to Copper CTD PMID:15359738 copper(0) multiple interactions ISO RGD:1321287 6480464 [Disulfiram binds to Copper] which results in increased expression of HNRNPA2B1 mRNA, [NSC 689534 binds to Copper] which results in decreased expression of HNRNPA2B1 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) affects localization ISO RGD:1321288 6480464 Copper affects the localization of HNRNPA2B1 protein CTD PMID:21146535 copper(0) increases expression ISO RGD:1321288 6480464 Copper results in increased expression of HNRNPA2B1 mRNA more ... CTD PMID:16629173 , PMID:21146535 coumarin increases phosphorylation ISO RGD:1321287 6480464 coumarin results in increased phosphorylation of HNRNPA2B1 protein CTD PMID:35688186 cyclosporin A decreases expression ISO RGD:1321287 6480464 Cyclosporine results in decreased expression of HNRNPA2B1 mRNA CTD PMID:21163907 , PMID:25562108 diallyl trisulfide decreases expression ISO RGD:1321287 6480464 diallyl trisulfide results in decreased expression of HNRNPA2B1 protein CTD PMID:16344271 diarsenic trioxide decreases expression ISO RGD:1321287 6480464 Arsenic Trioxide results in decreased expression of HNRNPA2B1 protein CTD PMID:25419056 diazinon increases expression EXP 6480464 Diazinon results in increased expression of HNRNPA2B1 mRNA CTD PMID:29108742 dibenzo[a,l]pyrene increases expression ISO RGD:1321287 6480464 dibenzo(a, l)pyrene results in increased expression of HNRNPA2B1 protein CTD PMID:18495319 dicrotophos decreases expression ISO RGD:1321287 6480464 dicrotophos results in decreased expression of HNRNPA2B1 mRNA CTD PMID:28302478 dihydroartemisinin affects binding ISO RGD:1321287 6480464 artenimol analog binds to HNRNPA2B1 protein CTD PMID:26340163 disulfiram multiple interactions ISO RGD:1321287 6480464 [Disulfiram binds to Copper] which results in increased expression of HNRNPA2B1 mRNA CTD PMID:24690739 diuron decreases expression EXP 6480464 Diuron results in decreased expression of HNRNPA2B1 mRNA CTD PMID:25152437 diuron decreases expression ISO RGD:1321287 6480464 Diuron results in decreased expression of HNRNPA2B1 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO RGD:1321287 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HNRNPA2B1 mRNA CTD PMID:27188386 doxorubicin affects expression ISO RGD:1321287 6480464 Doxorubicin affects the expression of HNRNPA2B1 protein CTD PMID:29385562 ethanol increases expression ISO RGD:1321287 6480464 Ethanol results in increased expression of HNRNPA2B1 protein CTD PMID:20621659 eurycomanone decreases expression ISO RGD:1321287 6480464 eurycomanone results in decreased expression of HNRNPA2B1 protein CTD PMID:21903368 fenvalerate affects expression EXP 6480464 fenvalerate affects the expression of HNRNPA2B1 protein CTD PMID:33656234 flutamide increases expression EXP 6480464 Flutamide results in increased expression of HNRNPA2B1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1321288 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:1321288 6480464 Folic Acid results in decreased expression of HNRNPA2B1 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1321287 6480464 Formaldehyde results in decreased expression of HNRNPA2B1 mRNA CTD PMID:20655997 fructose multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in increased expression of HNRNPA2B1 protein CTD PMID:26930160 fructose decreases expression EXP 6480464 Fructose results in decreased expression of HNRNPA2B1 protein CTD PMID:26930160 fulvestrant decreases expression ISO RGD:1321287 6480464 fulvestrant results in decreased expression of HNRNPA2B1 mRNA CTD PMID:16514628 furan increases expression EXP 6480464 furan results in increased expression of HNRNPA2B1 mRNA CTD PMID:26194646 genistein increases expression ISO RGD:1321287 6480464 Genistein results in increased expression of HNRNPA2B1 protein CTD PMID:20884965 genistein multiple interactions ISO RGD:1321287 6480464 ESR2 promotes the reaction [Genistein results in increased expression of HNRNPA2B1 protein] CTD PMID:20884965 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HNRNPA2B1 mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of HNRNPA2B1 mRNA CTD PMID:24136188 graphite increases expression ISO RGD:1321287 6480464 Graphite results in increased expression of HNRNPA2B1 protein CTD PMID:22157353 hyaluronic acid decreases expression EXP 6480464 Hyaluronic Acid analog results in decreased expression of HNRNPA2B1 protein CTD PMID:23178681 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of HNRNPA2B1 protein CTD PMID:23178681 inulin multiple interactions ISO RGD:1321288 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HNRNPA2B1 mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:1321287 6480464 Ivermectin results in decreased expression of HNRNPA2B1 protein CTD PMID:32959892 ketamine increases expression EXP 6480464 Ketamine results in increased expression of HNRNPA2B1 protein CTD PMID:18504422 L-methionine multiple interactions ISO RGD:1321288 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HNRNPA2B1 gene CTD PMID:20938992 lead diacetate increases expression ISO RGD:1321288 6480464 lead acetate results in increased expression of HNRNPA2B1 mRNA CTD PMID:21829687 lead(0) affects expression ISO RGD:1321287 6480464 Lead affects the expression of HNRNPA2B1 mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions ISO RGD:1321287 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of HNRNPA2B1 mRNA CTD PMID:35877022 methyl methanesulfonate decreases expression ISO RGD:1321287 6480464 Methyl Methanesulfonate results in decreased expression of HNRNPA2B1 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1321287 6480464 methylmercuric chloride results in increased expression of HNRNPA2B1 mRNA CTD PMID:23179753 , PMID:28001369 miconazole decreases expression ISO RGD:1321288 6480464 Miconazole results in decreased expression of HNRNPA2B1 mRNA CTD PMID:27462272 N-methyl-4-phenylpyridinium increases expression ISO RGD:1321288 6480464 1-Methyl-4-phenylpyridinium results in increased expression of HNRNPA2B1 protein CTD PMID:26558463 N-methylformamide decreases expression ISO RGD:1321288 6480464 methylformamide analog results in decreased expression of HNRNPA2B1 mRNA, methylformamide results in decreased expression of HNRNPA2B1 mRNA CTD PMID:17040096 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of HNRNPA2B1 mRNA CTD PMID:24136188 ouabain affects expression ISO RGD:1321287 6480464 Ouabain affects the expression of HNRNPA2B1 protein CTD PMID:17268060 p-chloromercuribenzoic acid increases expression ISO RGD:1321287 6480464 p-Chloromercuribenzoic Acid results in increased expression of HNRNPA2B1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1321287 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HNRNPA2B1 mRNA CTD PMID:27188386 paclitaxel decreases expression ISO RGD:1321287 6480464 Paclitaxel results in decreased expression of HNRNPA2B1 mRNA CTD PMID:15000894 paracetamol increases expression ISO RGD:1321287 6480464 Acetaminophen results in increased expression of HNRNPA2B1 mRNA CTD PMID:21420995 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of HNRNPA2B1 mRNA CTD PMID:33387578 paraquat increases expression ISO RGD:1321288 6480464 Paraquat results in increased expression of HNRNPA2B1 mRNA alternative form CTD PMID:17064354 paraquat decreases expression ISO RGD:1321288 6480464 Paraquat results in decreased expression of HNRNPA2B1 protein CTD PMID:27111068 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 pentanal decreases expression ISO RGD:1321287 6480464 pentanal results in decreased expression of HNRNPA2B1 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1321288 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HNRNPA2B1 mRNA more ... CTD PMID:36331819 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of HNRNPA2B1 mRNA CTD PMID:20345932 quercetin increases expression ISO RGD:1321287 6480464 Quercetin results in increased expression of HNRNPA2B1 protein CTD PMID:17292933 quercetin increases phosphorylation ISO RGD:1321287 6480464 Quercetin results in increased phosphorylation of HNRNPA2B1 protein CTD PMID:35688186 quercetin decreases expression ISO RGD:1321287 6480464 Quercetin results in decreased expression of HNRNPA2B1 protein CTD PMID:19207037 quercetin increases expression EXP 6480464 Quercetin results in increased expression of HNRNPA2B1 mRNA CTD PMID:21565894 raloxifene decreases expression ISO RGD:1321287 6480464 Raloxifene Hydrochloride results in decreased expression of HNRNPA2B1 mRNA CTD PMID:16514628 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of HNRNPA2B1 mRNA CTD PMID:25905778 resveratrol multiple interactions ISO RGD:1321287 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of HNRNPA2B1 mRNA CTD PMID:23557933 resveratrol decreases expression ISO RGD:1321288 6480464 resveratrol results in decreased expression of HNRNPA2B1 protein CTD PMID:25505154 SB 431542 multiple interactions ISO RGD:1321287 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HNRNPA2B1 mRNA CTD PMID:27188386 silicon dioxide affects secretion ISO RGD:1321287 6480464 Silicon Dioxide analog affects the secretion of HNRNPA2B1 protein CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:1321288 6480464 Silicon Dioxide results in decreased expression of HNRNPA2B1 mRNA CTD PMID:19073995 succimer multiple interactions ISO RGD:1321288 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPA2B1 mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1321287 6480464 Sunitinib results in decreased expression of HNRNPA2B1 mRNA CTD PMID:31533062 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of HNRNPA2B1 protein CTD PMID:26141394 tetracaine decreases expression ISO RGD:1321288 6480464 Tetracaine results in decreased expression of HNRNPA2B1 mRNA CTD PMID:34822839 tetraphene increases expression ISO RGD:1321288 6480464 benz(a)anthracene results in increased expression of HNRNPA2B1 mRNA CTD PMID:26377693 thapsigargin decreases expression ISO RGD:1321287 6480464 Thapsigargin results in decreased expression of HNRNPA2B1 mRNA CTD PMID:22378314 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of HNRNPA2B1 protein CTD PMID:35544339 Tributyltin oxide increases phosphorylation ISO RGD:1321288 6480464 bis(tri-n-butyltin)oxide results in increased phosphorylation of HNRNPA2B1 protein CTD PMID:22174045 trichloroethene decreases methylation EXP 6480464 Trichloroethylene results in decreased methylation of HNRNPA2B1 gene CTD PMID:27618143 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of HNRNPA2B1 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1321287 6480464 trichostatin A results in decreased expression of HNRNPA2B1 protein CTD PMID:19294695 trimellitic anhydride increases expression ISO RGD:1321288 6480464 trimellitic anhydride results in increased expression of HNRNPA2B1 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of HNRNPA2B1 mRNA CTD PMID:30589522 triphenylstannane increases expression ISO RGD:1321287 6480464 triphenyltin analog results in increased expression of HNRNPA2B1 protein CTD PMID:31634547 tunicamycin decreases expression ISO RGD:1321287 6480464 Tunicamycin results in decreased expression of HNRNPA2B1 mRNA CTD PMID:22378314 urethane increases expression ISO RGD:1321288 6480464 Urethane results in increased expression of HNRNPA2B1 protein CTD PMID:17477362 urethane decreases expression ISO RGD:1321287 6480464 Urethane results in decreased expression of HNRNPA2B1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:1321287 6480464 Valproic Acid results in decreased methylation of HNRNPA2B1 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:1321287 6480464 Valproic Acid results in decreased expression of HNRNPA2B1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:1321287 6480464 Valproic Acid affects the expression of HNRNPA2B1 mRNA CTD PMID:25979313 vanadyl sulfate decreases expression ISO RGD:1321287 6480464 vanadyl sulfate results in decreased expression of HNRNPA2B1 mRNA CTD PMID:16330358 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of HNRNPA2B1 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of HNRNPA2B1 mRNA CTD PMID:23555832 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of HNRNPA2B1 mRNA CTD PMID:22570695 vincristine decreases expression ISO RGD:1321287 6480464 Vincristine results in decreased expression of HNRNPA2B1 mRNA CTD PMID:23649840